Figure 4From: High-dose antioxidants for central serous chorioretinopathy; The randomized placebo-controlled study The mean central macular thickness (CMT) at each follow-up time between the study and control group. Study group (group A): the group received antioxidant tablets, Control group (group B): the group received placebo tablets, CMT = central macular thickness. Back to article page